Mission
To run clinical research to international standards in the Colombian Caribbean, giving our population access to investigational therapies and giving sponsors a site that executes.
Who we are
An independent research site built in the Colombian Caribbean.
Allied Research Society Colombia S.A.S. was founded in 2022 in Barranquilla to give international sponsors a regulated, self-contained site in a region with high disease burden and limited research infrastructure.
Vision
To be the reference clinical research site of the Colombian Caribbean for sponsors, CROs and academic partners working on tropical, infectious and chronic disease.
Objectives
Lead clinical research in oncology, infectious disease and general medicine; guarantee the highest standards of patient safety and quality in line with SISPRO, SUPERSALUD and MINSALUD; invest in the continuous training of our team; and contribute to the community through research that transforms medicine.
Institutional video
A look inside the site.
Our facilities, our investigators and how a study runs here, in the video our team produced.
Ecosystem
One ecosystem, three arms.
-
Allied Research Society
The clinical research site: investigators, infrastructure, study execution.
-
Global Disease Research Foundation
The non-profit arm, focused on public health research and grant-funded work.
-
Associated IPS
The licensed health provider that anchors patient care and clinical operations.
Track record
Timeline
-
2022
Founded in Barranquilla
Allied Research Society Colombia S.A.S. is constituted.
-
2022
IPS licence
Licensed as an IPS by the Colombian Ministry of Health and Social Protection.
-
2022
Institutional ethics committee
Our own ethics committee is constituted to review protocols.
-
2024
GCP certification
Good Clinical Practice certification granted by INVIMA under Resolution 2378 of 2008, authorising Phase I–IV clinical studies.
-
Today
Recognised research group
Research group recognised by Minciencias, with an active multi-therapeutic portfolio.
Governance
Our own institutional ethics committee.
Protocol review does not depend on an external board. Our institutional ethics committee is an independent body, INVIMA-certified in 2024, and reviews clinical studies, observational studies and academic work — including brochures, amendments, university protocols and student theses. That in-house review shortens the path between site selection and first patient in.
